Thursday, 21 October 2021 09:16 GMT

Vanda Pharmaceuticals Announces Participation at Evercore ISI's Catalyst Day


(MENAFN- PR Newswire) WASHINGTON, Oct. 14, 2021 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA ) today announced that it will participate at Evercore ISI's Catalyst Day on Monday, October 18, 2021. Mihael H. Polymeropoulos, M.D., Vanda's President, CEO and Chairman of the Board, will take part in a virtual fireside chat at 1:30 PM ET.

About Vanda Pharmaceuticals Inc.

Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit and follow us on Twitter @vandapharma.

Corporate Contact:

AJ Jones II Chief Corporate Affairs and Communications Officer Vanda Pharmaceuticals Inc. (202) 734-3400 [email protected]

Elizabeth Van Every Head of Corporate Affairs Vanda Pharmaceuticals Inc. (202) 734-3400 [email protected]

Kevin Moran Senior Vice President, Chief Financial Officer and Treasurer Vanda Pharmaceuticals Inc. (202) 734-3400 [email protected]

SOURCE Vanda Pharmaceuticals Inc.

Related Links


MENAFN14102021003732001241ID1102973351


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.